Skip to content
A

Aref Chelal

Publications (4)

Stage IV Non-small Cell Lung Adenocarcinoma in Complete Response for 5 Years Post-first-line Nivolumab Immunotherapy: Are We Talking about a Cure?

Aref Chelal, Ashraf ALakkad, Ashok Uttamchandani & Sonia Otsmane · International Journal of Medical and Pharmaceutical Case Reports · 2022

Background: Metastasis of the Central Nervous System (CNS) is one of the frequently occurring complications of advanced Non-Small Cell Lung Cancer (NSCLC) and has been observed in 24–44% of patients. Patients suffering from NSCLC along with CNS metastases have a generally poor pr...

Open access Research Article 10.9734/ijmpcr/2022/v15i430170

Complete Response to Pembrolizumab in a Patient with Lynch Syndrome: A Case Report

Aref Chelal & Ashraf ALakkad · International Research Journal of Gastroenterology and Hepatology · 2022

Background: Lynch syndrome LS is a life-threatening condition caused by heterozygous mutations in mismatch repair genes (MMR). People with this syndrome are at increased risk of developing different types of cancers, such as colorectal carcinomas, endometrial cancer, and ovarian...

Open access Research Article

Lung Cancer: Solitary Pulmonary Nodule

Ashraf ALakkad, Aref Chelal & James Aitchison · Journal of Cancer and Tumor International · 2022

A 55-year old, middle-aged man, known for hypertension and dyslipidemia, presented to the OPD with complaints of fever along with a mild dry cough. There was no shortness of breath or chest pain associated with the patient’s complaints. Therefore, as a seemingly obvious diagnosis...

Open access Research Article 10.9734/jcti/2022/v12i230174